Journals Library

HTA - 11/36/29

Oral Versus Intravenous Antibiotics (OVIVA) for Bone and Joint Infection

Project title: Oral Versus Intravenous Antibiotics (OVIVA) for Bone and Joint Infection

Call to action: 11/36 HTA Clinical Trials - November 2011 Board submission (May 2011 deadline)

Research type: Primary Research

Chief investigator: Dr Matthew ScarboroughORCID logo

Lead Author: Dr Matthew ScarboroughORCID logo

Contractor: Oxford University Hospitals NHS Trust

Cost: £932,220.00

Co-investigators: Associate Professor Rachel Kerr (nee Midgley)ORCID logo, Dr Andrew SeatonORCID logo, Dr Philip BejonORCID logo, Mr Martin McNallyORCID logo, Professor Andrew BriggsORCID logo, Professor Ann WalkerORCID logo, Professor Guy ThwaitesORCID logo, Professor Hemant PanditORCID logo.

Started: March 2013 | Status: Published August 2019

ISRCTN: 91566927

Oral antibiotic therapy is non-inferior to intravenous antibiotic therapy when used during the first 6 weeks in management of bone and joint infection, and saves around £2740 per patient.

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked


How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.